Michael A. Boss
Plus aucun poste en cours
Profil
Michael A.
Boss held several former positions in various companies, including Vice President at Elan Corp.
Plc, Vice President-Operations at Blueprint Genetics, Inc., General Manager-Autoimmune at Sarossa Capital Ltd., Vice President-Research & Development at Genica Pharmaceuticals Corp., and Chief Operating & Business Officer at Antisoma, Inc. He was also a Member at Massachusetts Institute of Technology.
Boss received his undergraduate, MBA, and doctorate degrees from the University of London.
Anciens postes connus de Michael A. Boss
| Sociétés | Poste | Fin |
|---|---|---|
Blueprint Genetics, Inc.
 Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Directeur des opérations | - |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
| Genica Pharmaceuticals Corp. | Directeur des opérations | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Formation de Michael A. Boss
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Blueprint Genetics, Inc.
Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Commercial Services |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
| Genica Pharmaceuticals Corp. | Commercial Services |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
